ANNOUNCEMENT

NOBEL PRIZE 2026

This year's laureates, their fields, and the discoveries that earned them the prize.Live nowSee the winners
Moonbase
← Back to Awards
NIHNATIONAL CANCER INSTITUTE

Translational and Clinical Research (TACR)

Active
Institution
UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI
Principal investigator
Theodore S Lawrence
Funding
$120K
Duration
1997–2028
Open portfolio

Moonbase score

Still being scored

Abstract

The Translational and Clinical Research (TACR) Program catalyzes collaborations along the laboratorytranslational-clinical research continuum and across solid tumor disease sites in the University of Michigan (UM) Rogel Cancer Center (Rogel). TACR represents a crucial bridging mechanism for the Rogel, linking its laboratory and population science based-research programs that generate innovative concepts, agents, and approaches that TACR translates to solid tumor patient-oriented research. The TACR program has three Specific Aims: 1) Develop and apply state-of-the-art molecularly targeted approaches to cancer diagnosis and treatment; 2) Develop and test new predictive biomarker and disease-monitoring strategies across tumor types; and 3) Advance concepts emanating from Rogel Cancer Center scientific programs to impactful clinical trials.

LOADING MOONBASE SCORE

NATIONAL CANCER INSTITUTEP30Cancer Centers Study Section (A)[NCI-A]solidrogeltumorpredictive biomarkersolid tumorconceptscancer centertranslational clinical

Questions for UNIVERSITY OF MICHIGAN AT ANN ARBOR

Answered by the team behind this research.

No questions yet. Sign in to ask the first one

Related grants

Same researchers, same institution, same topic, scored first.